The regulator sounded the alarm after reviewing reports of anticoagulant- associated kidney damage.
The regulator sounded the alarm after reviewing reports of anticoagulant- associated kidney damage.
End of content
No more pages to load
From The Source
- Medibank ramps up real-time intervention to retain insurance customers
- Digitalised primary care in the UK: a qualitative study of the experiences of minoritised ethnic communities
- EMPHN Strategic Plan 2025-2028
- AMPLIA ENTERS INTO PRECLINICAL COLLABORATION WITH KOREAN SPECIALIST DRUG SCREENING COMPANY NEXT&BIO
- Neuren announces A$50 million on-market share buy-back program
- TGA and InstantScripts reach settlement
- DoHAC: National anti-vaping program for young Australians
- Designs unveiled for new Maitland Mental Health facility
- Increased support for women with severe menopause symptoms
- Tamworth Hospital receives $415,000 for facility upgrades
- NSW to rollout new free RSV prevention program in 2025
- Narrabri Hospital to receive $70,000 for outdoor upgrades